Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-09-001647
Filing Date
2009-03-11
Accepted
2009-03-10 20:17:56
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 ALTUS PHARMACEUTICALS INC. b73447ape10vk.htm 10-K 1277439
2 EX-10.40 THIRD AMENDMENT TO DRUG PRODUCT PRODUCTION AND CLINICAL SUPPLY AGREEMEN b73447apexv10w40.htm EX-10.40 17220
3 EX-23.1 CONSENT OF ERNST & YOUNG LLP b73447apexv23w1.htm EX-23.1 1418
4 EX-23.2 CONSENT OF DELOITTE & TOUCHE LLP b73447apexv23w2.htm EX-23.2 1349
5 EX-31.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER SECTION 302 b73447apexv31w1.htm EX-31.1 5904
6 EX-31.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER SECTION 302 b73447apexv31w2.htm EX-31.2 5928
7 EX-32.1 CERTIFICATE OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFIC b73447apexv32w1.htm EX-32.1 3780
8 GRAPHIC b73447apb7344701.gif GRAPHIC 8897
  Complete submission text file 0000950135-09-001647.txt   1326857
Mailing Address 125 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 125 SIDNEY STREET CAMBRIDGE MA 02139 617-299-2900
Altus Pharmaceuticals Inc. (Filer) CIK: 0001340744 (see all company filings)

EIN.: 043573277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51711 | Film No.: 09671021
SIC: 2836 Biological Products, (No Diagnostic Substances)